Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide's dual receptor mechanism How tirzepatide works: Dual GIP/GLP-1 receptor agonist Single molecule, two pathways GIP (glucose-dependent insulinotropic polypeptide) + GLP-1 Weekly subcutaneous injection FDA approved for diabetes and obesity GIP pathway effects: Enhances insulin secretion Improves insulin sensitivity Promotes fat metabolism Reduces inflammation Works synergistically with GLP-1 GLP-1 pathway effects: Suppresses appetite (central brain effects) Slows gastric emptying (moderate) Increases satiety Reduces glucagon Improves glucose control Combined tirzepatide results: 15-22% average body weight loss (monotherapy) Superior to semaglutide (GLP-1 alone) Well-tolerated in trials Approved and available See our tirzepatide dosing guide , semaglutide vs tirzepatide , and peptides for weight loss at SeekPeptides
Delivered directly into the bloodstream, IV therapy ensures higher absorption and faster results compared to oral supplements
fast shipping easy process The injection really have helped with my weight loss
Set shifting and reversal learning Rats were food restricted (15 g food/day) until they reached 85% of their initial body weight and habituated to a food reward (45 mg sucrose pellets
Methods: In this phase 3 multicenter, randomized, double-blind, placebo-controlled study, subjects were randomized 1:1:1 to receive once-daily oral placebo, OCA 10 mg, or OCA 25 mg
US$ 27.04
US$ 27.06
US$ 29.66
US$ 22.00
